Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 89 (PPIAP89)

Target
PPIAP89
Molecular classification
Other (Pseudogene)
01

Overview

Peptidylprolyl isomerase A pseudogene 89 (PPIAP89) is a member of the PPIA pseudogene family found in the human genome. Pseudogenes are DNA sequences similar to known genes but are nonfunctional due to disabling mutations such as frameshifts or premature stop codons. PPIAP89 shares sequence similarity with the functional peptidylprolyl isomerase A gene (PPIA), which encodes cyclophilin A, an enzyme involved in protein folding and various cellular regulatory processes. Unlike its parent gene, PPIAP89 does not encode a functional protein and does not have a verified physiological or pathological protein function. Some pseudogenes, in certain contexts, can exert regulatory effects at the transcriptional or post-transcriptional levels, such as by acting as decoys for microRNAs or generating regulatory RNAs, but these roles have not been specifically documented for PPIAP89. PPIAP89 appears in genome databases (HGNC: 53713; NCBI Gene: 442460; Ensembl: ENSG00000223819) and is annotated as a pseudogene, which is generally not a classical receptor, enzyme, or drug target. There is no evidence implicating PPIAP89 as a biomarker, direct disease gene, or target of any approved or investigational drugs.

02

Biological functions

Possible regulatory roles at the RNA level through mechanisms like miRNA sponging or generation of regulatory noncoding RNAs, but not established enzymatic or receptor-associated functions
03

Disease associations

Other (pseudogenes can have regulatory functions in cancer and other diseases, but there is no specific disease role described for PPIAP89)

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 89 (PPIAP89).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 89 (PPIAP89).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call